Sandimmune and Weight loss - a phase IV clinical study of FDA data

Summary:

Weight loss is reported as a side effect among people who take Sandimmune (cyclosporine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Norvasc, and have High blood pressure.

The phase IV clinical study analyzes which people have Weight loss when taking Sandimmune. It is created by eHealthMe based on reports of 6,679 people who have side effects when taking Sandimmune from the FDA, and is updated regularly.

What is Sandimmune?

Sandimmune has active ingredients of cyclosporine. eHealthMe is studying from 6,694 Sandimmune users. Check the latest studies of Sandimmune.

What is Weight loss?

Weight loss is found to be associated with 1,449 drugs and 2,293 conditions by eHealthMe. Check the latest studies of Weight loss.

On Apr, 24, 2026

6,679 people reported to have side effects when taking Sandimmune.
Among them, 13 people (0.19%) have Weight loss.

Among these 13 people:

How long have people been on Sandimmune when they have Weight loss? *

What is the gender of people who have Weight loss when taking Sandimmune? *

female: 46.15 %
male: 53.85 %

What is the age of people who have Weight loss when taking Sandimmune? *

What are other drugs people take besides Sandimmune? *

What are other side effects people have besides Weight loss? *

High Blood Pressure: 8 people, 61.54%
Hepatic Steatosis (fatty liver disease): 5 people, 38.46%
Xerosis (abnormal dryness of the skin or mucus membranes): 4 people, 30.77%
Lymphoedema (localized fluid retention and tissue swelling): 4 people, 30.77%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 30.77%
Joint Pain: 4 people, 30.77%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 4 people, 30.77%
Infection: 4 people, 30.77%
Venous Insufficiency (poor circulation of blood caused by damaged or enlarged veins): 4 people, 30.77%
Toxic Shock Syndrome (a rare but serious medical condition caused by a bacterial infection): 3 people, 23.08%

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 38.46%
Uveitis (inflammation of the uvea): 2 people, 15.38%
Seasonal Allergy (allergic condition due to certain season): 2 people, 15.38%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 2 people, 15.38%
Genital Rash (rash on sex organ): 2 people, 15.38%
Anaemia (lack of blood): 2 people, 15.38%
Allergic Rhinitis: 2 people, 15.38%
Abdominal Pain: 2 people, 15.38%
Menstruation Irregular: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Sandimmune and have Weight loss?

- Check whether Weight loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sandimmune:

Sandimmune (6,694 reports)

Weight loss treatments and more:

Weight loss (62,430 reports)

Browse all side effects of Sandimmune:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight loss:

Weight loss (1,449 drugs)

Browse all the conditions that are associated with Weight loss:

Weight loss (2,293 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Sandimmune) and Sandimmune (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.